Comparison of the enzymatic and cellular profiles of clinical JAK inhibitors for the treatment of myelofibrosis. [PDF]
Celik H +11 more
europepmc +1 more source
Genetic Risk Factors and Clinical Implications of Glaucoma in the Saudi Population: A Review. [PDF]
Alotaibi AF +5 more
europepmc +1 more source
Recurrent evolution of ligand-binding domain multiplicity fine-tunes TGFβ signaling in vertebrates. [PDF]
Jatzlau J +13 more
europepmc +1 more source
ACVR mutation [NM_001105.4:c.774G>T (p.Arg258Ser)] in pediatric fibrodysplasia ossificans progressiva complicated by scoliosis: a case report. [PDF]
Yang F, Liu M, Pei S, Huang J, Wang H.
europepmc +1 more source
Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva. [PDF]
Rosenberg NM +6 more
europepmc +1 more source
Interdisciplinary Study of the Clinical Phenotype of Patients with Fibrodysplasia Ossificans Progressiva (FOP) in Dental Practice: A Cross-Sectional Clinical-Statistical Analysis. [PDF]
Danshina S +6 more
europepmc +1 more source
Effects of miR-128-3p on Renal Inflammation in a Rat Periodontitis Model. [PDF]
Nurhamim M +7 more
europepmc +1 more source
Primary Cilia Are Required for Efficient BMP Signaling in Traumatic Heterotopic Ossification. [PDF]
Yuan X +9 more
europepmc +1 more source
Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth. [PDF]
Kato S +15 more
europepmc +1 more source
Management of splenomegaly in patients with myelofibrosis in the era of JAK inhibitors: a comprehensive review. [PDF]
Al-Asa'd Y +4 more
europepmc +1 more source

